Correlation Between Alto Neuroscience, and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alto Neuroscience, and Eli Lilly and, you can compare the effects of market volatilities on Alto Neuroscience, and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Eli Lilly.

Diversification Opportunities for Alto Neuroscience, and Eli Lilly

-0.72

Correlation Coefficient

Alto Neuroscience,  Eli Lilly

Pay attention - limited upside

The 3 months correlation between Alto and Eli is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Eli Lilly go up and down completely randomly.

Pair Corralation between Alto Neuroscience, and Eli Lilly

Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Eli Lilly. In addition to that, Alto Neuroscience, is 2.55 times more volatile than Eli Lilly and. It trades about -0.15 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.07 per unit of volatility. If you would invest  79,277  in Eli Lilly and on December 26, 2024 and sell it today you would earn a total of  5,958  from holding Eli Lilly and or generate 7.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Alto Neuroscience,  vs.  Eli Lilly and

Alto Neuroscience,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alto Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eli Lilly

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish essential indicators, Eli Lilly may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Alto Neuroscience, and Eli Lilly

The main advantage of trading using opposite Alto Neuroscience, and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind Alto Neuroscience, and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.